Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Development of an immune or autoimmune response involves T-cell activation in lymphoid organs and subsequent migration to peripheral tissues. Here we show that T-cell-specific ablation of the kinase TBK1 promotes T-cell activation but causes retention of effector T cells in the draining lymph node in a neuroinflammatory autoimmunity model, experimental autoimmune encephalomyelitis (EAE). At older ages, the T-cell-conditional TBK1-knockout mice also spontaneously accumulate T cells with activated phenotype. TBK1 controls the activation of AKT and its downstream kinase mTORC1 by a mechanism involving TBK1-stimulated AKT ubiquitination and degradation. The deregulated AKT-mTORC1 signalling in turn contributes to enhanced T-cell activation and impaired effector T-cell egress from draining lymph nodes. Treatment of mice with a small-molecule inhibitor of TBK1 inhibits EAE induction. These results suggest a role for TBK1 in regulating T-cell migration and establish TBK1 as a regulator of the AKT-mTORC1 signalling axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent studies have demonstrated critical roles for TBK1 and/or IKK ε in regulation of activity of numerous immune cell types, including T cells 21 , B cells 22,23 , dendritic cells 24 , and macrophages 25,26 .”
From Targeting TBK1 to overcome resistance to cancer immunotherapy (2023) · cites this paper as [21]
Experimental — accuracy not yet measuredIn the citing paper
“In keeping with this, Tbk1 deletion disrupts the migration of T-cells [216] that may exert anti-inflammatory effects in ALS models [192,217].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [216]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452 · cited 1×
“The T-cell priming and differentiation are governed by signal transduction mediated by the TCR and a costimulatory molecule, CD28, as well as cytokine signals 6 .”
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,676
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759 · cited 2×
“In vitro T-cell migration assays were performed using a 24-well plate Boyden chamber essentially as previously described 33 .”
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740 · cited 1×
“The central nervous system (CNS) is an organ of a number of autoimmune and inflammatory disorders, including multiple sclerosis, a disease characterized by chronic inflammation, demyelination, and neuronal damage 2 .”
Triggering the Interferon Antiviral Response Through an IKK-Related Pathway
Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G.-P., Lin, R., & Hiscott, J. (2003) · Science · doi:10.1126/science.1081315 · Cited by 1,661
Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1716 · Cited by 1,206 · cited 1×
“5) 22–24 .”
Regulation and function of mTOR signalling in T cell fate decisions
Chi, H. (2012) · Nature Reviews Immunology · doi:10.1038/nri3198 · Cited by 1,035
Autoimmune T cell responses in the central nervous system
Goverman, J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2550 · Cited by 1,030 · cited 1×
“It is generally believed that in MS and EAE, autoimmune T cells are primed by myelin-specific antigens and then migrate across the blood-brain barrier to enter the CNS, where they become reactivated and mediate inflammation and neuronal damage 4,5 .”
Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice
Arbonés, M. L., Ord, D. C., Ley, K., Ratech, H., Maynard-Curry, C., Otten, G., Capon, D. J., & Teddert, T. F. (1994) · Immunity · doi:10.1016/1074-7613(94)90076-0 · Cited by 831 · cited 1×
“2d), they did not have a defect in T-cell homing to the lymph nodes as shown for the CD62L-deficient mice 19,20 .”
The integration of T cell migration, differentiation and function
Masopust, D., & Schenkel, J. M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3442 · Cited by 627 · cited 1×
“Newly activated T cells express low levels of the factors involved in T-cell migration, particularly the transcription factor KLF2 and its target gene product S1PR1, which is correlated with the lymphoid retention of the T cells 39 .”
Cited by
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Jenkins, R. W., Aref, A. R., Lizotte, P. H., Ivanova, E., Stinson, S., Zhou, C. W., Bowden, M., Deng, J., Liu, H., Miao, D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0833 · Cited by 594
“To determine if MDOTS profiling predicted in vivo response to dual TBK1/IKKε inhibition, BALB/c mice bearing CT26 tumors were treated with Cmpd 1 ± anti–PD-L1 (Fig.”
BackgroundInfluentialKinase inhibition in autoimmunity and inflammation
Zarrin, A. A., Bao, K., Lupardus, P., & Vucic, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0082-8 · Cited by 431
Oduro, P. K., Zheng, X., Wei, J., Yang, Y., Wang, Y., Zhang, H., Liu, E., Gao, X., Du, M., & Wang, Q. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.011 · Cited by 339
Inflammation in ALS/FTD pathogenesis
McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 341
“Interestingly, when challenged with the EAE model, ablating TBK1 in T cells led to retention of effector T cells in the draining lymph nodes, resulting in decreased numbers of T cells infiltrating into the brain, and a less severe disease phenotype [165].”
BackgroundTBK1: a new player in ALS linking autophagy and neuroinflammation
Oakes, J. A., Davies, M. C., & Collins, M. O. (2017) · Molecular Brain · doi:10.1186/s13041-017-0287-x · Cited by 319
“Migration of T cells from the lymph nodes is impaired in TBK1 knockout mice [39], potentially resulting in decreased T cell number in the CNS.”
BackgroundNeuroinflammation in frontotemporal dementia
Bright, F., Werry, E. L., Dobson-Stone, C., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kassiou, M., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0231-z · Cited by 280
Luo, W., Wang, Y., Zhang, L., Ren, P., Zhang, C., Li, Y., Azares, A. R., Zhang, M., Guo, J., Ghaghada, K. B., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.041460 · Cited by 286
Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease
Burberry, A., Suzuki, N., Wang, J.-Y., Moccia, R., Mordes, D. A., Stewart, M. H., Suzuki-Uematsu, S., Ghosh, S., Singh, A., Merkle, F. T., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6038 · Cited by 269
“Our findings, and those that indicate T cell function becomes compromised in mice harboring mutations in additional ALS-implicated genes (19,31), suggest that investigating whether C9orf72 functions in this cell type is warranted.”
The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism
Bai, J., & Liu, F. (2019) · Diabetes · doi:10.2337/dbi18-0052 · Cited by 243
“This result is in agreement with the findings of others that TBK1 inhibits mTORC1 activity in prostate cancer cells (59,60) and in an experimental autoimmune encephalomyelitis model (60).”
ResultTargeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy
Di Pilato, M., Kim, E. Y., Cadilha, B. L., Prüßmann, J. N., Nasrallah, M. N., Seruggia, D., Usmani, S. M., Misale, S., Zappulli, V., Carrizosa, E., et al. (2019) · Nature · doi:10.1038/s41586-019-1215-2 · Cited by 210
Autophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189
“In keeping with this, Tbk1 deletion disrupts the migration of T-cells [216] that may exert antiinflammatory effects in ALS models [192,217].”
BackgroundTargeting TBK1 to overcome resistance to cancer immunotherapy
Sun, Y., Revach, O.-Y., Anderson, S., Kessler, E. A., Wolfe, C. H., Jenney, A., Mills, C. E., Robitschek, E. J., Davis, T. G. R., Kim, S., et al. (2023) · Nature · doi:10.1038/s41586-023-05704-6 · Cited by 174
Type I interferon signaling, regulation and gene stimulation in chronic virus infection
Lukhele, S., Boukhaled, G. M., & Brooks, D. G. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.05.001 · Cited by 165
The role of TBK1 in cancer pathogenesis and anticancer immunity
Runde, A. P., Mack, R. M., Breslin, P., & Zhang, J. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02352-y · Cited by 172
“T cell-specific deletion of Tbk1 leads to increased sensitivity of T cells to activating stimuli, an increased fraction of the T-cell population being in either the T effector (Teff) or T memory (Tmem) state at the expense of the T naïve (Tn) population, and impaired exit of Teff from lymph nodes [2].”
BackgroundInfluentialInsights into T‐cell dysfunction in Alzheimer's disease
Dai, L., & Shen, Y. (2021) · Aging Cell · doi:10.1111/acel.13511 · Cited by 117
TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis
Zhu, L., Li, Y., Xie, X., Zhou, X., Gu, M., Jie, Z., Ko, C.-J., Gao, T., Hernandez, B. E., Cheng, X., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0429-8 · Cited by 109
Self-citationZhou, X., Yu, J., Cheng, X., Zhao, B., Manyam, G. C., Zhang, L., Schluns, K. S., Li, P., Wang, J., & Sun, S. (2019) · Nature Immunology · doi:10.1038/s41590-019-0405-2 · Cited by 116
Self-citationTBK1, a central kinase in innate immune sensing of nucleic acids and beyond
Zhou, R., Zhang, Q., & Xu, P. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa051 · Cited by 104
cGAS‒STING signaling and function in metabolism and kidney diseases
Bai, J., & Liu, F. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab066 · Cited by 106
“, 2018), and mTOR signaling (Yu et al., 2015; Hasan et al., 2017) under various cellular conditions.”
BackgroundHasan, M., Gonugunta, V. K., Dobbs, N., Ali, A., Palchik, G., Calvaruso, M. A., DeBerardinis, R. J., & Yan, N. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611113114 · Cited by 98
“T cell-specific ablation of TBK1 also enhances mTORC1 signaling in an experimental autoimmune encephalomyelitis model (20).”
BackgroundTherapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies
Hasan, M., & Yan, N. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.008 · Cited by 83
Li, L., Zhu, Z., Zhao, W., Tao, S., Li, B., Xu, S.-Z., Wang, J., Zhang, M., Wu, J., Leng, R., et al. (2018) · Immunology · doi:10.1111/imm.12940 · Cited by 100
Xiao, Y., Zou, Q., Xie, X., Liu, T., Li, H. S., Jie, Z., Jin, J., Hu, H., Manyam, G., Zhang, L., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161524 · Cited by 87
“…ligands, many other agents, such as inflammatory cytokines, the TNF superfamily of co-stimulatory factors, and T cell receptor stimuli, stimulate TBK1 activation, although not all of these agents induce type I IFN expression (Clark et al., 2009; Jin et al., 2012; Liu et al., 2015; Yu et al., 2015).”
InfluentialSelf-citationHeterozygous Tbk1 loss has opposing effects in early and late stages of ALS in mice
Brenner, D., Sieverding, K., Bruno, C., Lüningschrör, P., Buck, E., Mungwa, S., Fischer, L., Brockmann, S. J., Ulmer, J., Bliederhäuser, C., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180729 · Cited by 83
“, 2012) and modulation of IFN signaling and inflammatory responses (Hemmi et al., 2004; Jin et al., 2012; Hasan et al., 2015, 2017; Yu et al., 2015).”
BackgroundRoles for the IKK-Related Kinases TBK1 and IKKε in Cancer
Durand, J. K., Zhang, Q. H., & Baldwin, A. S. (2018) · Cells · doi:10.3390/cells7090139 · Cited by 78
“[25] established TBK1 as a regulator of the Akt-mTORC1 signaling axis.”
BackgroundSuppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
Deng, K., Wang, A., Ji, Y., Zhang, X., Fang, J., Zhang, Y., Zhang, P., Jiang, X., Gao, L., Zhu, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms11432 · Cited by 69
TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity
Louis, C., Burns, C. J., & Wicks, I. P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00434 · Cited by 71
“One study using conditional TBK1−/− in CD4+ T cells (Tbk1fl/fl:CD4-Cre mice) and stimulation with TCR and CD28, suggested that basal TBK1 is required for constitutive AKT turnover to prevent hyperactivation of AKT upon T cell activation (124).”
BackgroundGuo, W., Vandoorne, T., Steyaert, J., Staats, K. A., & Bosch, L. V. D. (2020) · Brain · doi:10.1093/brain/awaa022 · Cited by 62
Jiang, Y., Chen, S., Li, Q., Liang, J., Lin, W., Li, J., Liu, Z., Wen, M., Cao, M., & Hong, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612139 · Cited by 64
“Recently, it was reported that TBK1 restrains the activation and migration of T cells, which are the main type of lymphocytes involved in the antitumor immune response (14, 15).”
BackgroundAging weakens Th17 cell pathogenicity and ameliorates experimental autoimmune uveitis in mice
Li, H., Zhu, L., Wang, R., Xie, L., Ren, J., Ma, S., Zhang, W., Liu, X., Huang, Z., Chen, B., et al. (2021) · Protein & Cell · doi:10.1007/s13238-021-00882-3 · Cited by 54
“The interaction with autoantigens results in the proliferation and activation of autoreactive T cells and B cells, as well as the formation of germinal center (GC) in LNs, thus initiating autoimmune diseases (Muñoz et al., 2010; Yu et al., 2015; Theofilopoulos et al., 2017).”
BackgroundTBK1 inhibitors: a review of patent literature (2011 – 2014)
Yu, T., Yang, Y., Yin, D. Q., Hong, S., Son, Y.-J., Kim, J.-H., & Cho, J. Y. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1081168 · Cited by 54
“TBK1 also acts as a key regulator in neuroinflammation, microvascular inflammation and gastritis [26-28].”
BackgroundIκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response
Zhang, J., Feng, H., Zhao, J., Feldman, E. R., Chen, S.-Y., Yuan, W., Huang, C., Akbari, O., Tibbetts, S. A., & Feng, P. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.083 · Cited by 53
“TBK-1, but not IKKε, was recently shown to modulate neuroinflammation in CD4+ T cells via the AKT-mTORC1 (mammalian target of rapamycin complex 1) signaling pathway (Yu et al., 2015).”
BackgroundXu, X., Han, L., Zhao, G., Xue, S., Gao, Y., Xiao, J., Zhang, S., Chen, P., Wu, Z.-Y., Ding, J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160068 · Cited by 53
“rESuLtS docK8 expression is enhanced in the acute phase of murine EAE Great efforts have been made to identify critical signaling proteins involved in T lymphocyte adhesion and migration (Wang et al., 2010; Zhang and Wang, 2012; Yu et al., 2015).”
BackgroundAstragaloside IV protects against the pathological cardiac hypertrophy in mice
Zhen-hu, L., Liu, H., & Wang, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.092 · Cited by 50
Duan, W., Guo, M., Yi, L., Zhang, J., Bi, Y., Liu, Y., Li, Y., Li, Z., Ma, Y., Zhang, G., et al. (2019) · Aging · doi:10.18632/aging.101936 · Cited by 53
Targeting TANK-binding kinase 1 (TBK1) in cancer
Revach, O., Liu, S., & Jenkins, R. W. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1826929 · Cited by 54
Mitophagy Modulation, a New Player in the Race against ALS
Madruga, E., Maestro, I., & Martínez, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020740 · Cited by 44
“TBK1−/− T cells show a reduced migration to the central nervous system (CNS), which could reduce the number of T cells infiltrated in the CNS and result in increased damage from ALS [65].”
BackgroundPositive Selection of a Serine Residue in Bat IRF3 Confers Enhanced Antiviral Protection
Banerjee, A., Zhang, X., Yip, A., Schulz, K. S., Irving, A. T., Bowdish, D. M. E., Golding, B., Wang, L., & Mossman, K. L. (2020) · iScience · doi:10.1016/j.isci.2020.100958 · Cited by 46
A review on the role of TANK-binding kinase 1 signaling in cancer
Alam, M., Hasan, G. M., & Hassan, M. I. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.06.022 · Cited by 45
Quan, M., Song, X., Liu, H.-J., Deng, X.-H., Hou, H.-Q., Li-ping, C., Ma, T., Han, X., He, X.-X., Jia, Z., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1438-z · Cited by 46
Borlido, J., Sakuma, S., Raíces, M., Carrette, F., Tinoco, R., Bradley, L. M., & D’Angelo, M. A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0103-5 · Cited by 40
Zhou, Z., Xu, J., Liu, S., Lv, Y., Zhang, R., Zhou, X., Zhang, Y., Weng, S., Xu, H. W., Ba, Y., et al. (2024) · Biomarker Research · doi:10.1186/s40364-024-00630-9 · Cited by 40
“The regulatory mechanisms of CARD11 deficiency include not only the failure of NF-κB signaling [130]. but also reduced expression and TCR-induced phosphorylation of the JUN. Additionally, there are alterations in the phosphorylation of Forkhead box O1 (Foxo1) [131].”
BackgroundSelf-citationCentral Modulation of Neuroinflammation by Neuropeptides and Energy-Sensing Hormones during Obesity
Maldonado‐Ruiz, R., Fuentes‐Mera, L., & Camacho‐Morales, A. (2017) · BioMed Research International · doi:10.1155/2017/7949582 · Cited by 39
“Both TCR and CD28 lead to the transcriptional factor AP-1 nuclear translocation, inducing the expression of IL-2 [31].”
BackgroundInfluentialMyeloid cell TBK1 restricts inflammatory responses
Gao, T., Liu, T., Ko, C., Zhang, L., Joo, D., Xie, X., Zhu, L., Li, Y., Cheng, X., & Sun, S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107742119 · Cited by 39
Self-citationEsteves, A. M., Papaevangelou, E., Prokar Dasgupta, A., & Galustian, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.621550 · Cited by 37
“Indeed, TBK1 is not active in wild type T cells in mice or in Jurkats, unless the cells are stimulated by PMA/Ionomycin (55).”
BackgroundIL-17 axis accelerates the inflammatory progression of obese in mice via TBK1 and IKBKE pathway
Lee, S., Jhun, J., Byun, J.-K., Kim, E., Jung, K., Lee, J. E., Choi, J. Y., Park, S., & Cho, M. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.02.004 · Cited by 32
Feng, Y., Chen, Y., Meng, Y., Cao, Q., Liu, Q., Ling, C., & Wang, C. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1426434 · Cited by 33
“that TBK1 can promote the migration of melanoma cells and the migration of T cells.(49,50) Therefore, targeting TBK1 may”
BackgroundIntestinal Epithelial TBK1 Prevents Differentiation of T-helper 17 Cells and Tumorigenesis in Mice
Yang, J., Jie, Z., Mathews, A., Zhou, X., Li, Y., Gu, M., Xie, X., Ko, C., Cheng, X., Qi, Y., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.07.047 · Cited by 34
Self-citationHemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43 transgenic mice
Sieverding, K., Ulmer, J., Bruno, C., Satoh, T., Tsao, W., Freischmidt, A., Akira, S., Wong, P. C., Ludolph, A. C., Danzer, K. M., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113496 · Cited by 34
Carata, E., Muci, M., Giulio, S. D., Mariano, S., & Panzarini, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411251 · Cited by 35
“The involvement of TBK1 mutations in neuroinflammation during ALS relies on the removal of T cells protective regulation (due to the ability of CD4+ cells in stabilizing microglial activation, decreasing pro-inflammatory cytokines, and increasing growth factor IGF-1) observed in both the spinal cord lesions of ALS pat…”
BackgroundTCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex
Shi, J., & Sun, S. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.024 · Cited by 34
“Consistently, the steady level of AKT is elevated in the TBK1-deficient T cells, coupled with enhanced phosphorylation of both the mTORC1-dowstream targets, S6K1 and S6, and the AKT substrate Foxo1 (Yu et al., 2015).”
BackgroundInfluentialSelf-citationKurarinone regulates Th17/Treg balance and ameliorates autoimmune uveitis via Rac1 inhibition
Gu, C., Liu, Y., Lv, J., Zhang, C., Huang, Z., Jiang, Q., Gao, Y., Tao, T., Su, Y., Chen, B., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.013 · Cited by 30
Glibenclamide Prevents Diabetes in NOD Mice
Lamprianou, S., Gysemans, C. A., Saab, J. B., Pontes, H., Mathieu, C., & Meda, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168839 · Cited by 26
Louis, C., Ngo, D., D’Silva, D. B., Hansen, J. A., Phillipson, L. J., Jousset, H., Novello, P. M., Segal, D., Lawlor, K. E., Burns, C. J., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40670 · Cited by 28
“Of note, conditional TBK- 1 deletion in CD4+ T cells has been shown to augment effector Th1 responses, and it renders these effector T helper cells incapable of exiting the secondary lymphoid tissue in experimental autoimmune encephalomyelitis (a model of multiple sclerosis), due to the greatly enhanced expression of…”
BackgroundInfluentialUnderstanding the role of cGAS-STING signaling in ischemic stroke: a new avenue for drug discovery
Chauhan, C., & Kaundal, R. K. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2244409 · Cited by 28
“[12] Entinostat (MS275) Ischemic stroke In-vivo Suppress cGAS transcription by inhibiting HDAC3 [11] Trichostatin A (TSA) Ischemic stroke In-vivo Suppress cGAS transcription by inhibition of HDAC3 [11] Brefedin A Amyotrophic lateral sclerosis (ALS) In-vitro and In-vivo Inhibit STING trafficking [156,157] Leptomycin B…”
BackgroundRehman, R., Tar, L., Olamide, A. J., Li, Z., Kassubek, J., Böckers, T. M., Weishaupt, J. H., Ludolph, A. C., Wiesner, D., & Roselli, F. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.684171 · Cited by 25
Myeloid TBK1 Signaling Contributes to the Immune Response to Influenza
Hagan, R. S., Torres-Castillo, J. L., & Doerschuk, C. M. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0122oc · Cited by 27
Gomez, J. C., Dang, H., Kanke, M., Hagan, R. S., Mock, J. R., Kelada, S. N. P., Sethupathy, P., & Doerschuk, C. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-11638-7 · Cited by 26
Lee, M. S. J., Inoue, T., Ise, W., Matsuo-Dapaah, J., Wing, J. B., Temizoz, B., Kobiyama, K., Hayashi, T., Patil, A., Sakaguchi, S., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20211336 · Cited by 21
“…of IFN regulatory factor 3/7 (IRF3/7), TBK1 is also involved in various signaling pathways in a cell type – specific manner (Xiao et al., 2017; Jin et al., 2012; Zhao et al., 2018) and in adaptive immunity (Jin et al., 2012; Yu et al., 2015; Pedros et al., 2016; Marichal et al., 2011).”
BackgroundEmerging roles of TBK1 in cancer immunobiology
Miranda, A., Shirley, C. A., & Jenkins, R. W. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.02.007 · Cited by 39
Sun, Y., Maggs, L., Panda, A., Wright, S. J., Cicerchia, A. M., Jenney, A., Perricone, M. D., Mills, C. E., Cattaneo, G., Ventin, M., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-1011 · Cited by 21
TBK1 as a regulator of autoimmunity and antitumor immunity
Shi, J., Xie, X., & Sun, S. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.165 · Cited by 19
Self-citationLork, M., Kreike, M., Staal, J., & Beyaert, R. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00040 · Cited by 20
“Jurkat T cells were stimulated with 200 ng/ml PMA and 1µM Ionomycin or 20µg/ml anti-CD3 and anti-CD28 or 1,000 U/ml TNF for the indicated times.”
BackgroundInfluentialAlam, M., Ansari, M. M., Noor, S., Mohammad, T., Hasan, G. M., Kazim, S. N., & Hassan, M. I. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.157 · Cited by 22
Duan, R., Wang, T., Li, Z., Jiang, L., Yu, X., He, D., Tao, T., Liu, X., Huang, Z., Feng, L., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03308-z · Cited by 19
Roles of IκB kinase ε in the innate immune defense and beyond
Zhang, J., Tian, M., Xia, Z., & Feng, P. (2016) · Virologica Sinica · doi:10.1007/s12250-016-3898-y · Cited by 19
“In addition to IFN treatment, T cell receptor engagement and calcium influx potently activated IKKε in T cells (Peters et al., 2000; Yu et al., 2015; Zhang et al., 2016).”
BackgroundInfluentialShan, S., Zhou, Y. L., Yu, J., Yang, Q., Pan, D., Wang, Y., Li, L., Zhu, J.-Z., Zhang, Y. L., Huang, S., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105914 · Cited by 18
Self-citationXie, J., Cheng, J., Ko, H., & Tang, Y. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00046-w · Cited by 18
“…that the administration of Amlexanox alleviates EAE severity by directly suppressing TBK1-dependent activation and migration of memory and naive T cells, or by indirectly interrupting T cell recruitment and activation through inhibiting the maturation of DC cells (Quan et al, 2019; Yu et al, 2015).”
BackgroundTANK-Binding Kinase 1 in the Pathogenesis and Treatment of Inflammation-Related Diseases
Lü, H., Chen, X., Huang, M., Jiang, Y., & Liu, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051941 · Cited by 17
“However, in another trial, TBK1-specific knockout in T cells impaired the migratory function of T cells, leading to lymph node T-cell retention and a decrease in the number of T cells in the CNS, which inhibited the occurrence of EAE in mice [79].”
InfluentialBruno, C., Sieverding, K., Freischmidt, A., Satoh, T., Walther, P., Mayer, B., Ludolph, A. C., Akira, S., Yilmazer‐Hanke, D., Danzer, K. M., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa133 · Cited by 18
“, 2012), innate and adaptive immune responses (Hemmi et al., 2004, Jin et al., 2012; Yu et al., 2015), energy metabolism (Reilly et al.”
BackgroundAbadey, A. A., Connor, B. J., Flamme, A. C. L., & Robichon, K. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110449 · Cited by 14
Vaden, R. M., Oswald, N. W., Potts, M. B., MacMillan, J. B., & White, M. A. (2017) · Marine Drugs · doi:10.3390/md15030075 · Cited by 15
UBQLN2 Promotes the Production of Type I Interferon via the TBK1-IRF3 Pathway
Chen, T., Zhang, W., Huang, B., Chen, X., & Huang, C. (2020) · Cells · doi:10.3390/cells9051205 · Cited by 12
Duan, W., Yi, L., Tian, Y., Huang, H.-P., Li, Z., Bi, Y., Guo, M., Li, Y., Liu, Y., Ma, Y., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02235-3 · Cited by 13
Sharma, R., Wu, K., Han, K. K., Russo, A. C., Dagur, P. K., Combs, C. A., Yao, X., Levine, S. J., & Sack, M. N. (2024) · Allergy · doi:10.1111/all.16461 · Cited by 15
“In contrast, the conditional knockout of TBK1 in CD4 + T cells resulted in the induction of IFN-γ and of CD4 + memory cells, and the pharmacologic inhibition of TBK1 blunted experimental autoimmune encephalitis [47].”
Abnormal regulation of the antiviral response in neurological/neurodegenerative diseases
Lam, M. M. W., Mapletoft, J., & Miller, M. S. (2016) · Cytokine · doi:10.1016/j.cyto.2016.09.002 · Cited by 10
Expression and prognostic role of IKBKE and TBK1 in stage I non-small cell lung cancer
Wang, X., Teng, F., Lu, J., Mu, D., Zhang, J., & Yu, J. (2019) · Cancer Management and Research · doi:10.2147/cmar.s204924 · Cited by 9
Self-citationChai, L., Li, C., Wang, X., Qin, Y., Sun, H., Du, J., Liu, Y., Hu, D., Xiong, J., Zhao, Z., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116336 · Cited by 10
Endothelial deletion of TBK1 contributes to BRB dysfunction via CXCR4 phosphorylation suppression
Zhao, B., Ni, Y., Zhang, H., Zhao, Y., & Li, L. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01222-y · Cited by 10
“found that T-cell-specific Tbk1 ablation mice showed splenomegaly as well as increased numbers of CD4 and CD8 T cells in lymphoid organs and the peripheral blood [17].”
BackgroundTBK 1 is involved in M‐ CSF ‐induced macrophage polarization through mediating the IRF 5/ IRF 4 axis
Li, Y., Ji, L., Liu, C., Li, J., Wen, D., Li, Z., Yu, L., Guo, M., Zhang, S., Duan, W., et al. (2024) · FEBS Journal · doi:10.1111/febs.17297 · Cited by 11
IRF5 knockdown reverses TDP-related phenotypes partially by increasing TBK1 expression
Li, Y., Yu, L., Liu, C., Duan, W., Zhang, S., Li, Z., Yi, L., Guo, M., Bi, Y., Li, C., et al. (2022) · Brain Research · doi:10.1016/j.brainres.2022.148155 · Cited by 8
Tumor-on-a-Chip: Microfluidic Models of Hypoxic Tumor Microenvironment
Parihar, A., Choudhary, N. K., Parihar, D. S., & Khan, R. (2023) · Springer eBooks · doi:10.1007/978-981-99-0313-9_14 · Cited by 9
Zeng, Y., Ng, J. P. L., Wang, L., Xu, X., Law, B. Y. K., Chen, G., Lo, H. H., Yang, L., Yang, J., Zhang, L., et al. (2023) · Inflammation Research · doi:10.1007/s00011-023-01809-w · Cited by 10
“Another study also reported that TBK1 inhibitor greatly delayed the onset and decreased the severity of experimental autoimmune encephalomyelitis (EAE), and even suppressed the relapse of EAE [75].”
ResultMARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1
Li, X., Cheng, K., Shang, M.-D., Yang, Y., Hu, B., Wang, X., Wei, X.-D., Han, Y., Zhang, X., Dong, M.-H., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-12667-y · Cited by 8
“Since acting an important role in diverse cellular processes, such as immunity and autophagy [16, 39–41], the activity of TBK1 needs to be fine-tuned.”
BackgroundHagan, R. S., Gomez, J. C., Torres-Castillo, J. L., Martin, J. R., & Doerschuk, C. M. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0311oc · Cited by 7
Anti-Inflammatory Effects of Chaenomeles sinensis Extract in an ALS Animal Model
Yang, E. J., & Lee, S. H. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2812326 · Cited by 7
“In addition, T cells and CD4+ cells are involved in neuroinflammation in ALS, and abnormal T-cell activation and differentiation in TANK-binding kinase 1 (TBK1) knockout mice augment neuroinflammation via an increase in Foxo 1 phosphorylation [ 26].”
BackgroundHui, L., Huang, M.-K., Dai, Q., Miao, C.-L., Yang, Y.-L., Liu, C., Liu, T., & Jiang, Y.-M. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae082 · Cited by 7
In Silico Insights: QSAR Modeling of TBK1 Kinase Inhibitors for Enhanced Drug Discovery
Ivanov, J. M., Tenchov, R., Ralhan, K., Iyer, K. A., Agarwal, S., & Zhou, Q. A. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00864 · Cited by 7
Wang, T., Duan, R., Li, Z., Zhang, B., Jiang, Q., Jiang, L., Lv, J., Su, W., & Feng, L. (2025) · JCI Insight · doi:10.1172/jci.insight.184072 · Cited by 7
“Lymph nodes (LNs) are pivotal in activating T cells and initiating autoimmune responses (14–17).”
Loss of C9orf72 function leads to autoimmunity
Sakkas, L. I., Bogdanos, D. P., & Kousvelari, E. E. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.01.33 · Cited by 6
Sorosina, M., Barizzone, N., Clarelli, F., Anand, S. K., Lupoli, S., Salvi, E., Mangano, E., Bordoni, R., Roostaei, T., Mascia, E., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11109-8 · Cited by 6
“Contrary to TBKBP1, for which few reports are available regarding its function, TBK1 is involved in several immune processes, including T-cell homeostasis and migration cells from lymph nodes to the CNS in the MS murine model [36].”
BackgroundA systems and computational biology perspective on advancing CAR therapy
Tserunyan, V., & Finley, S. D. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.05.009 · Cited by 6
TBK1 is involved in programmed cell death and ALS-related pathways in novel zebrafish models
Raas, Q., Haouy, G., de Calbiac, H., Pasho, E., Marian, A., Guerrera, I. C., Rosello, M., Oeckl, P., Bene, F. D., Catanese, A., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02374-3 · Cited by 6
Inhibition of TBK1 reduces choroidal neovascularization in vitro and in vivo
Cui, K., Zhang, S., Liu, X., Yan, Z., Huang, L., Yang, X., Zhu, R., & Sang, A. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.003 · Cited by 5
Almeida, M. S., Bezbradica, J. S., & Coban, C. (2026) · Current Opinion in Virology · doi:10.1016/j.coviro.2026.101545 · Cited by 5
Crosstalk and Prospects of TBK1 in Inflammation
Liu, H., Sheng, Q., Dan, J., & Xie, X. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2392587 · Cited by 5
“Studies have shown that T-cell-specific ablation of TBK1 enhances T-cell activation and differentiation but hampers the lymph node egress of T cells, disrupting T-cell homeostasis (J. Yu et al., 2015).”
Zheng, Y., Sasidharan-Nair, V., Buchta, T., Bonifacius, A., Khan, F., Pietzsch, B., Ahmadi, H., Beckstette, M., Niemz, J., Hilgendorf, P., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012581 · Cited by 6
“Although it is well known that the kinase TBK1 can be activated by various signals, including TCR signalling [53,67], the role of its adaptor protein TBKBP1 in CD8 + T cells remains unidentified.”
Functional Involvement of TANK‐Binding Kinase 1 in the MyD88‐Dependent NF‐ κ B Pathway Through Syk
Kim, H. G., Kim, J. H., Yu, T., & Cho, J. Y. (2024) · Mediators of Inflammation · doi:10.1155/2024/8634515 · Cited by 5
Brains in Metamorphosis: Temporal Transcriptome Dynamics in Hatchery-Reared Flatfishes
Guerrero-Peña, L., Suárez‐Bregua, P., Méndez-Martínez, L., García-Fernández, P., Tur, R., Rubiolo, J. A., Tena, J. J., & Rotllant, J. (2021) · Biology · doi:10.3390/biology10121256 · Cited by 5
“It is generally believed that the development of an immune response involves T-cell activation in lymphoid organs and subsequent migration to peripheral tissues to mediate tissue damage inflammation [52].”
Background
Metadata
- Authors
- Yu, J., Zhou, X., Chang, M., Nakaya, M., Chang, J.-H., Xiao, Y., William Lindsey, J., Dorta-Estremera, S., Cao, W., Zal, A., Zal, T., & Sun, S.-C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Fukui (JP)
- Corresponding author
- Sun, Shao-Cong
- ORCID
- Venue
- Nature Communications
- Published
- 2015-01-21
- Volume
- 6
- Issue
- 1
- Pages
- 6074-6074
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4302769
- OpenAlex
- W1963961512
- Cited by
- 118
- References
- 53
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 18 · 2023: 8 · 2022: 8 · 2021: 13 · 2020: 9 · 2019: 12 · 2018: 12 · 2017: 10 · 2016: 10 · 2015: 2
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (AI064639)
- University of Texas MD Anderson Cancer Center (P30-CA-016672, AI057555, AI104519)
- National Cancer Institute (R01CA181184, P30CA016672)
- National Institute of General Medical Sciences (GM84459, R01GM084459)
- National Institute of Allergy and Infectious Diseases (AI064639, R01AI057555, R37AI064639, R01AI064639, R01AI104519, AI104519, AI057555)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- TBK1, T cell activation, T cell migration, neuroinflammation, experimental autoimmune encephalomyelitis, Akt, mTORC1, draining lymph nodes, TBK1 inhibitors, autoimmunity
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Cell Movement, Cell Separation, Central Nervous System, Encephalomyelitis, Autoimmune, Experimental, Female, Gene Expression Regulation, Humans, Lymphocyte Activation, Macrophages, Male, Mice, Inbred C57BL, Orthomyxoviridae, Phenotype, Phosphorylation, T-Lymphocytes, Signal Transduction, CD4-Positive T-Lymphocytes, Autoimmunity, Protein Serine-Threonine Kinases, Mice, Knockout, CD8-Positive T-Lymphocytes, Jurkat Cells, Multiprotein Complexes, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.